Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

8 medical device companies that beat the COVID-19 pandemic and prospered

March 29, 2021 By Danielle Kirsh

Edwards LifesciencesEdwards Lifesciences: +0.9%

2020 revenue: $4,386,300,000

R&D spending up 1.1%

Headcount up 6.4%

Edwards Lifesciences represents an exception to the rule. Its structural heart devices often weren’t directly combatting the COVID-19 pandemic, but they were so needed to preserve people’s lives that procedure volumes quickly recovered.

The Irvine, Calif.–based company ended 2020 with $4.386 billion in sales, a 0.9% increase from the year prior when the company made $4.348 billion. Edwards previously grew 16.8% from 2018 to 2019, logging $3.7 billion in sales in 2018.

Edwards LifeSciences paused enrollments in its pivotal mitral, tricuspid trials in response to the COVID-19 pandemic to allow for hospital systems to reallocate resources to potential surges in the coronavirus. Despite the halt, Edwards spent $760.7 million on research and development last year, representing a 1.1% growth from 2019 when it spent $752.7 million on R&D. In comparison, the company’s R&D spending rose 21% from 2018 to 2019 when there wasn’t a global pandemic to contend with.

“Structural heart patients were severely impacted beginning in March, experiencing significant difficulties entering the system, which also had a profound impact on second-quarter procedures, and even though healthcare systems adapted to the challenge, the resurgence of COVID that began late in the year continues to impact structural heart patients, who need care,” CEO Michael Mussallem said during an earnings call transcribed by The Motley Fool. “We continue to invest in developing solutions that extend lives, improve the quality of life and offer greater value for the healthcare system.”

Edwards Lifesciences also employed 900 more people during the year of COVID-19, bringing its total employment to 14,900 to represent a 6.4% year-over-year growth from 2019. The hiring isn’t too far off from how the company trended in the past. Between 2018 and 2019, the company employed 1,200 more people to represent a 9.4% growth in its employee count.

Throughout 2020, Edwards reached numerous regulatory milestones for its TAVR and heart valve technologies. The company won EU approval in May for its Pascal transcatheter valve repair system for tricuspid repair. It also won FDA approval for its Konect Resilia aortic valve conduit for complex aortic valve surgeries.

“We celebrated some exciting milestones in 2020 that directly impacted patients. In TAVR, despite headwinds, more than 100,000 patients benefited from treatment with Sapien valves worldwide. In surgical structural heart, we launched our Konect aortic valved conduit and Inspiris became the leading aortic surgical valve worldwide,” Mussallem said. “We’ve seen early positive clinical evidence across the TMTT platform, physician feedback is encouraging and patient outcomes have been distinguished. And in critical care, we met the increased demand for core pressure monitoring products due to the pandemic, and we’re proud that we were able to help over 1 million patients globally with our monitoring technology.”

Next >>

Pages: 1 2 3 4 5 6 7 8 9 10

About The Author

Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Related Articles Read More >

This is a screenshot of the remote robotic surgery technical guidelines appearing in the World Journal of Surgery.
New technical guidelines set to advance remote robotic surgery
An illustration of Embolization Inc.'s Nitinol Enhanced Device (NED).
This nitinol vascular embolization device has another shape memory material up its sleeve
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
A photo of Johnson & Johnson MedTech's Polyphonic-connected Monarch robotics-assisted bronchoscopy system in the lab.
J&J MedTech’s global head of digital wants to fund your AI project
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe